RecruitingLGMD1BLGMD1CLGMD1D
Long-Term Development of Muscular Dystrophy Outcome Assessments
Eligible age
6–50 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).
Sponsor: Virginia Commonwealth University
You may qualify if…
- ✓ 1. Age between 6-50 years at enrollment
- ✓ 2. Clinically affected (defined as weakness on bedside evaluation in a pattern consistent with proximal weakness)
- ✓ 3. Genetic confirmation of a LGMD, DM2, or LOPD
- ✓ 4. FVC above 30% of predicted
You may not qualify if…
- ✕ 1. Any other illness that would interfere with the ability to undergo safe testing or would interfere with interpretation of the results in the opinion of the site investigator
- ✕ 2. Participation in a clinical trial receiving an investigational product
Where it's recruiting
Virginia
Richmond
Source: ClinicalTrials.gov · NCT05989620 · last updated 2025-11-18